LAURA TIMCIUC: Open Payments
NPI 1831734821 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 13 payments from 4 companies in 2025. Trend: 2023 $191 · 2024 $953 · 2025 $1,763
Consulting: $1,374Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $1,531 |
| Immunocore Limited | 3 | $185 |
| Iovance Biotherapeutics, Inc. | 2 | $30 |
| ARRAY BIOPHARMA INC | 1 | $17 |
Products named: KIMMTRAK, OPDUALAG, Amtagvi, BRAFTOVI.
Industry payments across TX — which companies pay providers there.
